Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL
- PMID: 8760802
- PMCID: PMC2192715
- DOI: 10.1084/jem.184.2.485
Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL
Abstract
Experimental data suggest that negative selection of thymocytes can occur as a result of supraoptimal antigenic stimulation. It is unknown, however, whether such mechanisms are at work in mature CD8+ T lymphocytes. Here, we show that CD8+ effector cytotoxic T lymphocytes (CTL) are susceptible to proliferative inhibition by high dose peptide antigen, leading to apoptotic death mediated by TNF-alpha release. Such inhibition is not reflected in the cytolytic potential of the CTL, since concentrations of antigen that are inhibitory for proliferation promote efficient lysis of target cells. Thus, although CTL have committed to the apoptotic pathway, the kinetics of this process are such that CTL function can occur before death of the CTL. The concentration of antigen required for inhibition is a function of the CTL avidity, in that concentrations of antigen capable of completely inhibiting high avidity CTL maximally stimulate low avidity CTL. Importantly, the inhibition can be detected in both activated and resting CTL. Blocking studies demonstrate that the CD8 molecule contributes significantly to the inhibitory signal as the addition of anti-CD8 antibody restores the proliferative response. Thus, our data support the model that mature CD8+ CTL can accommodate an activation signal of restricted intensity, which, if surpassed, results in deletion of that cell.
Similar articles
-
Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes.J Exp Med. 1991 Apr 1;173(4):849-58. doi: 10.1084/jem.173.4.849. J Exp Med. 1991. PMID: 1901079 Free PMC article.
-
Antigen recognition by H-2-restricted cytolytic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen.Eur J Immunol. 1988 Nov;18(11):1863-6. doi: 10.1002/eji.1830181135. Eur J Immunol. 1988. PMID: 3144458
-
Selective induction of high avidity CTL by altering the balance of signals from APC.J Immunol. 2003 Mar 1;170(5):2523-30. doi: 10.4049/jimmunol.170.5.2523. J Immunol. 2003. PMID: 12594278
-
Molecular mechanisms and biological significance of CTL avidity.Curr HIV Res. 2003 Jul;1(3):287-94. doi: 10.2174/1570162033485230. Curr HIV Res. 2003. PMID: 15046253 Review.
-
Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.Ann Ist Super Sanita. 1990;26(3-4):369-84. Ann Ist Super Sanita. 1990. PMID: 2151107 Review.
Cited by
-
Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells.Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3545-50. doi: 10.1073/pnas.0307347101. Epub 2004 Mar 1. Proc Natl Acad Sci U S A. 2004. PMID: 14993609 Free PMC article.
-
Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen Compositions.Int J Mol Sci. 2022 Apr 15;23(8):4401. doi: 10.3390/ijms23084401. Int J Mol Sci. 2022. PMID: 35457221 Free PMC article.
-
DC-based cancer vaccines.J Clin Invest. 2007 May;117(5):1195-203. doi: 10.1172/JCI31205. J Clin Invest. 2007. PMID: 17476349 Free PMC article. Review.
-
MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors.J Clin Invest. 2010 Nov;120(11):3869-77. doi: 10.1172/JCI43437. Epub 2010 Oct 11. J Clin Invest. 2010. PMID: 20978348 Free PMC article.
-
B cells directly tolerize CD8(+) T cells.J Exp Med. 1998 Dec 7;188(11):1977-83. doi: 10.1084/jem.188.11.1977. J Exp Med. 1998. PMID: 9841912 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials